Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 941 | FEED ENvue Medical, Inc. Common Stock | 1.6200 USD | +3.18% | -12.91% | -8.47% | -64.94% | 1.76 M USD | ||
| 942 | BJDX Bluejay Diagnostics, Inc. Common Stock | 1.8601 USD | +0.01% | -7.92% | -0.53% | -4.61% | 1.81 M USD | ||
| 943 | KALA KALA BIO, Inc. Common Stock | 0.20 USD | -13.04% | +17.65% | -28.57% | -94.44% | 1.64 M USD | ||
| 944 | GOVX GeoVax Labs, Inc. New | 1.2800 USD | -4.48% | +5.61% | -27.27% | -11.72% | 1.52 M USD | ||
| 945 | GCTK GlucoTrack, Inc. Common Stock | 0.7407 USD | +0.80% | +8.18% | -38.79% | -54.84% | 1.44 M USD | ||
| 946 | BDRX Biodexa Pharmaceuticals plc American Depositary Shs | 3.3608 USD | +3.41% | -0.86% | +296.74% | +140.06% | 1.52 M USD | ||
| 947 | ITRM Iterum Therapeutics plc Ordinary Share | 0.03 USD | -57.14% | 0.00% | -81.25% | -97.56% | 1.34 M USD | ||
| 948 | RDHL Redhill Biopharma Ltd. | 0.8229 USD | +1.59% | +2.86% | -3.05% | -18.52% | 1.06 M USD | ||
| 949 | NCEL NewcelX Ltd. Ordinary Shares | 2.5650 USD | +1.79% | +19.30% | -8.03% | -49.51% | 810.42 K USD | ||
| 950 | MNDR Mobile-health Network Solutions Class A Ordinary Shares | 0.8028 USD | -3.91% | -5.97% | -9.80% | -20.51% | 711.12 K USD | ||
| 951 | VRAX Virax Biolabs Group Limited Ordinary Shares | 0.15 USD | 0.00% | -6.25% | -21.05% | -85.15% | 651.29 K USD | ||
| 952 | NIVF NewGenIvf Group Limited Class A ordinary shares | 2.2900 USD | +9.05% | +7.26% | -3.38% | +189.87% | 551.89 K USD | ||
| 953 | ONCO Onconetix, Inc. Common Stock | 0.7380 USD | -18.90% | -39.01% | +25.51% | -2.89% | 529.03 K USD | ||
| 954 | AKAN Akanda Corp. Common Shares | 3.06 USD | -2.24% | +337.14% | +260.00% | +163.79% | 400.95 K USD | ||
| 955 | ADTX Aditxt, Inc. Common Stock | 0.4288 USD | +1.83% | -17.54% | -76.44% | -26.07% | 387.84 K USD | ||
| 956 | XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares | 2.4000 USD | -1.84% | +2.56% | +267.93% | +167.26% | 330.52 K USD | ||
| 957 | HCTI Healthcare Triangle, Inc. Common Stock | 2.46 USD | -5.38% | +2.07% | -20.65% | +1071.43% | 297.72 K USD | ||
| 958 | SPRC SciSparc Ltd. Ordinary Shares | 3.36 USD | +3.70% | +1.20% | -22.94% | +1058.62% | 192.50 K USD | ||
| 959 | AKTX Akari Therapeutics plc ADR (0.01 USD) | 4.60 USD | -0.65% | +23.66% | +1900.00% | +286.55% | 131.63 K USD | ||
| 960 | CMND Clearmind Medicine Inc. Common Shares | 0.69 USD | -24.18% | -46.09% | -10.39% | -27.37% | 109.07 K USD |
Notizie Titoli del Settore Sanitario
MeiraGTx: Turning Dry Mouth Into Liquid Gold (NASDAQ:MGTX)
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market - GoodRx Holdings (NASDAQ:GDRX), Novo Nordisk
Jefferies conferma il rating su GeneDx citando la penetrazione di mercato
BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy (NASDAQ:BMRN)
1Q26 Earnings: Where Street Estimates Are Too Low And Who Should Beat
Jefferies alza il target di Allogene a $10 sui dati dello studio
Why Is Immutep Stock Soaring Today? - Immutep (NASDAQ:IMMP)
Gainers Titoli del Settore Sanitario
IMMP Immutep Limited American Depositary Shares | 0.63 | +103.23% |
NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0193 | +45.11% |
CUE Cue Biopharma, Inc. | 0.60 | +36.36% |
COSM Cosmos Holdings Inc. Common Stock | 0.42 | +27.27% |
EUDAW EUDA Health Holdings Limited Ordinary Shares | 0.0280 | +24.44% |
NOTV Inotiv, Inc. Common Stock | 0.31 | +24.00% |
TSHA Taysha Gene Therapies, Inc. Common Stock | 5.81 | +23.35% |
SCLXW Scilex Holding Company Common Stock | 0.1039 | +22.81% |
Losers Titoli del Settore Sanitario
BEAT Heartbeam, Inc. Common Stock | 0.81 | -32.50% |
WORX SC WORX Corp | 1.06 | -30.72% |
TOIIW The Oncology Institute, Inc. Common Stock | 0.0351 | -28.22% |
CMND Clearmind Medicine Inc. Common Shares | 0.69 | -24.18% |
TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
ONCO Onconetix, Inc. Common Stock | 0.7380 | -18.90% |
ALGS Aligos Therapeutics, Inc. Common Stock | 7.3900 | -15.45% |